
CDNA vs GRAL
$CDNA vs $GRAL head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
CDNA vs GRAL: trend, levels and the market
One year to 2026-11-19, against the S&P 500 (+8.8%). Split-adjusted daily closes.
- ·CDNA has the cleaner trend, above both its 50- and 200-day averages, where GRAL is above one and below the other.
- ·Both beat the market over the past year: CDNA +355% and GRAL +19.8%, against the S&P 500 at +8.8%.
- ·GRAL sits closer to its support, 11.1% above it at $93.52, while CDNA is 34.8% above its own at $47.13.
- ·GRAL is within 1.9% of resistance at $107.27, a price where it has stalled before.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
CDNA vs GRAL: the quick read
- ·GRAL is the larger company by market cap ($4.59B vs $3.91B).
- ·CDNA has been more active on our scanner (161 vs 143 alerts in 30 days).
- ·GRAL has the smaller float (44.2M vs 52.2M), which tends to mean sharper, more volatile moves.
- ·Both are services-medical laboratories names, so this is a like-for-like comparison and sector news tends to move them together.
- ·Both stay busy on our scanner, 161 and 143 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 17% of each other on market cap, which makes the rest of this table the interesting part.
- ·They are pulling apart today: GRAL is outperforming the other by roughly 5.9 percentage points on the session.
Objective differences only. Not investment advice.
Watching CDNA or GRAL? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing CDNA and GRAL on TheDesperateTrader.
- Is CDNA or GRAL the better stock?
- "Better" depends on your goal, and these two are not alike. GRAL is the larger company by market cap ($4.59B vs $3.91B). CDNA has been more active on our scanner (161 vs 143 alerts in 30 days). GRAL has the smaller float (44.2M vs 52.2M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between CDNA and GRAL?
- The differences that matter: they are similar in size ($3.91B vs $4.59B); they trade at very different share prices ($72.32 vs $105.22); CDNA sits at 75% of its 52-week range against 51% for GRAL; our scanner flagged CDNA 161 times in the last 30 days against 143 for GRAL. Everything above is measured from the latest completed session and SEC filings.
- Which of CDNA and GRAL is more active right now?
- Right now CDNA is at about 0.4x its normal volume and GRAL is at about 0.7x, so GRAL is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is CDNA or GRAL in the stronger trend?
- CDNA is above its 50-day average of $68.22 and above its 200-day average of $37.78; GRAL is below its 50-day average of $122.90 and above its 200-day average of $79.27. CDNA leads 5 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading CDNA or GRAL? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore CDNA and GRAL comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.